KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Novartis Ag (NVS) Gross Margin (2016 - 2025)

Historic Gross Margin for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to 1237.8%.

  • Novartis Ag's Gross Margin rose 11599900.0% to 1237.8% in Q4 2025 from the same period last year, while for Dec 2025 it was 1307.82%, marking a year-over-year increase of 12305200.0%. This contributed to the annual value of 78.81% for FY2025, which is 15100.0% up from last year.
  • Novartis Ag's Gross Margin amounted to 1237.8% in Q4 2025, which was up 11599900.0% from 1482.05% recorded in Q3 2025.
  • Novartis Ag's Gross Margin's 5-year high stood at 1581.89% during Q1 2025, with a 5-year trough of 69.74% in Q1 2021.
  • In the last 5 years, Novartis Ag's Gross Margin had a median value of 75.78% in 2022 and averaged 328.42%.
  • Per our database at Business Quant, Novartis Ag's Gross Margin crashed by -34200bps in 2021 and then skyrocketed by 15056000bps in 2025.
  • Novartis Ag's Gross Margin (Quarter) stood at 72.16% in 2021, then rose by 4bps to 74.93% in 2022, then rose by 2bps to 76.63% in 2023, then increased by 2bps to 77.81% in 2024, then surged by 1491bps to 1237.8% in 2025.
  • Its Gross Margin stands at 1237.8% for Q4 2025, versus 1482.05% for Q3 2025 and 1075.07% for Q2 2025.